Sensei Biotherapeutics Stock Performance
| SNSE Stock | USD 7.21 0.50 6.49% |
The entity has a beta of 1.31, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Sensei Biotherapeutics will likely underperform. Sensei Biotherapeutics right now has a risk of 4.57%. Please validate Sensei Biotherapeutics treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Sensei Biotherapeutics will be following its existing price patterns.
Risk-Adjusted Performance
Weak
Weak | Strong |
Over the last 90 days Sensei Biotherapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Sensei Biotherapeutics is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
Actual Historical Performance (%)
One Day Return (6.49) | Five Day Return (6.12) | Year To Date Return (30.00) | Ten Year Return (98.09) | All Time Return (98.09) |
Last Split Factor 1:20 | Last Split Date 2025-06-17 |
1 | Acquisition by Krebs Stephanie of 120000 shares of Sensei Biotherapeutics at 0.476 subject to Rule 16b-3 | 04/28/2025 |
2 | Sensei Biotherapeutics Expected to Announce Quarterly Earnings on Thursday | 05/01/2025 |
3 | Sensei Reports Encouraging Clinical Results in Recent Qua - GuruFocus | 05/07/2025 |
4 | Acquisition by English Jessie of 19000 shares of Sensei Biotherapeutics at 0.709 subject to Rule 16b-3 | 05/15/2025 |
5 | Acquisition by Ringo William R of 19000 shares of Sensei Biotherapeutics at 0.3202 subject to Rule 16b-3 | 05/21/2025 |
6 | Sensei Biotherapeutics stockholders approve key proposals - Investing.com | 05/23/2025 |
7 | Sensei Biotherapeutics Upgraded at HC Wainwright - Defense World | 06/03/2025 |
8 | Sensei Biotherapeutics Announces 1-for-20 Reverse Stock Split SNSE Stock News | 06/13/2025 |
9 | Sensei Biotherapeutics Trading Halted Amid Pending News SNSE Stock News - GuruFocus | 06/16/2025 |
10 | What analysts say about Sensei Biotherapeutics Inc. stock - Free Capital Efficiency Planning - Jammu Links News | 07/18/2025 |
11 | What drives Sensei Biotherapeutics Inc. stock price - Phenomenal capital gains - jammulinksnews.com | 07/22/2025 |
| Begin Period Cash Flow | 13 M | |
| Total Cashflows From Investing Activities | 22.4 M |
Sensei Biotherapeutics Relative Risk vs. Return Landscape
If you would invest 758.00 in Sensei Biotherapeutics on April 24, 2025 and sell it today you would lose (37.00) from holding Sensei Biotherapeutics or give up 4.88% of portfolio value over 90 days. Sensei Biotherapeutics is currently generating 0.0204% in daily expected returns and assumes 4.5738% risk (volatility on return distribution) over the 90 days horizon. In different words, 40% of stocks are less volatile than Sensei, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Sensei Biotherapeutics Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sensei Biotherapeutics' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Sensei Biotherapeutics, and traders can use it to determine the average amount a Sensei Biotherapeutics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0045
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | SNSE |
Estimated Market Risk
| 4.57 actual daily | 40 60% of assets are more volatile |
Expected Return
| 0.02 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Sensei Biotherapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sensei Biotherapeutics by adding Sensei Biotherapeutics to a well-diversified portfolio.
Sensei Biotherapeutics Fundamentals Growth
Sensei Stock prices reflect investors' perceptions of the future prospects and financial health of Sensei Biotherapeutics, and Sensei Biotherapeutics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Sensei Stock performance.
| Return On Equity | -0.64 | ||||
| Return On Asset | -0.35 | ||||
| Current Valuation | (22.04 M) | ||||
| Shares Outstanding | 1.26 M | ||||
| Price To Book | 0.28 X | ||||
| EBITDA | (32.61 M) | ||||
| Net Income | (30.16 M) | ||||
| Cash And Equivalents | 123.71 M | ||||
| Cash Per Share | 4.03 X | ||||
| Total Debt | 3.85 M | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 23.46 X | ||||
| Book Value Per Share | 25.38 X | ||||
| Cash Flow From Operations | (24.67 M) | ||||
| Earnings Per Share | (23.00) X | ||||
| Market Capitalization | 9.09 M | ||||
| Total Asset | 45.36 M | ||||
| Retained Earnings | (262.05 M) | ||||
| Working Capital | 36.48 M | ||||
About Sensei Biotherapeutics Performance
By analyzing Sensei Biotherapeutics' fundamental ratios, stakeholders can gain valuable insights into Sensei Biotherapeutics' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Sensei Biotherapeutics has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Sensei Biotherapeutics has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.66) | (0.70) | |
| Return On Capital Employed | (0.82) | (0.78) | |
| Return On Assets | (0.66) | (0.70) | |
| Return On Equity | (0.79) | (0.75) |
Things to note about Sensei Biotherapeutics performance evaluation
Checking the ongoing alerts about Sensei Biotherapeutics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Sensei Biotherapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Sensei Biotherapeutics had very high historical volatility over the last 90 days | |
| Sensei Biotherapeutics has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (30.16 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Sensei Biotherapeutics currently holds about 123.71 M in cash with (24.67 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.03. | |
| Sensei Biotherapeutics has a frail financial position based on the latest SEC disclosures | |
| Roughly 34.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: What drives Sensei Biotherapeutics Inc. stock price - Phenomenal capital gains - jammulinksnews.com |
- Analyzing Sensei Biotherapeutics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Sensei Biotherapeutics' stock is overvalued or undervalued compared to its peers.
- Examining Sensei Biotherapeutics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Sensei Biotherapeutics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Sensei Biotherapeutics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Sensei Biotherapeutics' stock. These opinions can provide insight into Sensei Biotherapeutics' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Sensei Stock analysis
When running Sensei Biotherapeutics' price analysis, check to measure Sensei Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sensei Biotherapeutics is operating at the current time. Most of Sensei Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Sensei Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sensei Biotherapeutics' price. Additionally, you may evaluate how the addition of Sensei Biotherapeutics to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |